-
F-CRIN launches a new call for expressions of interest
F-CRIN is launching a new call for expressions of interest to select a platform capable of strengthening its skills in supporting international clinical research projects. The closing date for applications is April 30, 2026.
-
Extremely premature babies: paracetamol helps the hearts of the most fragile
A vast European clinical study involving 800 very large and extremely premature infants hospitalized in 14 European countries is published today in the prestigious JAMA Pediatrics: the TREOCAPA study, coordinated by the PedStart pediatric clinical investigation network.
-
Obesity: as new medications gain momentum, experts set a framework
Faced with the boom in new drug treatments for obesity (TMO), GCC-CSO and the F-CRIN "FORCE" network have published a position paper aimed at providing a framework for their use in adults, clarifying their indications and reiterating the importance of long-term medical and nutritional support.
-
Is it possible to use fewer medications in care homes?
Is it possible to reduce treatments for the most frail elderly without endangering their health? A large-scale French clinical study, RETREAT-FRAIL, has produced reassuring results and opened up concrete prospects for improving the quality of life of EHPAD residents.
-
Stay up to date with F-CRIN news: subscribe to our newsletter
F-CRIN in brief
F-CRIN is a clinical research infrastructure established in 2012 and supported by Inserm. Its mission is to strengthen the competitiveness of French clinical research by creating a collective scientific and operational momentum, always in the service of patients.
Overall, F-CRIN brings together a workforce of more than 2,000 clinical research professionals spread across the country.
38 %
of projects with an international scope
1 083
clinical research projects involving F-CRIN
510
projects conducted with an industrial partner
2,895
scientific and international publications mentioning F-CRIN or its components
F-CRIN in France
F-CRIN is a federative organization structured around 28 components: thematic clinical research and investigation networks, expertise networks, a clinical research support platform, and a national coordination unit, which serves as the infrastructure’s headquarters, located in Toulouse.
